alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › epidemiological

epidemiological

2 studies tagged epidemiological, dated 2010-10-01 to 2018-04-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. When Do α-Synucleinopathies Start? An Epidemiological Timeline: A Review 2018-04-01
  2. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials 2010-10-01

Studies

2 studies carry this tag.

Date range

2010 to 2018

Top journals

  • Annals of the New York Academy of Sciences 1
  • JAMA neurology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. When Do α-Synucleinopathies Start? An Epidemiological Timeline: A Review

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. JAMA neurology 2018-04-01 Brain scans and imaging

    Characterizing the temporal onset of these conditions will help to better recognize the premotor phase of the α-synucleinopathies and specific clinical phenotypes and will guide the search for predictive biomarkers and risk or protective factors for Parkinson disease and other synucleinopathies.

  2. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Annals of the New York Academy of Sciences 2010-10-01 Genetics

    Inflammation may be an important mechanism underlying dementia and cognitive decline in the elderly.

All topic tags with their study counts